B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ADRA2C

MOLECULAR TARGET

adrenoceptor alpha 2C

UniProt: P18825NCBI Gene: 15276 compounds

ADRA2C (adrenoceptor alpha 2C) is targeted by 76 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADRA2C

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Yohimbine4.3476
2Oxymetazoline3.5835
3Clonidine3.5333
4Idazoxan3.5032
5Phentolamine3.3728
6Norepinephrine Precursor of epinephrine that is secreted by3.2224
7Epinephrine2.5612
8Mianserin2.4811
9Phenylephrine2.208
10Piperoxan2.087
11Dexmedetomidine1.956
12Naphazoline1.956
13Rilmenidine Oxazole derivative that acts as1.795
14Tolazoline1.795
15Quetiapine Fumarate1.614
16Pergolide1.614
17Aripiprazole1.393
18Bromocriptine1.393
19Carvedilol1.393
20Dihydroergotamine1.393
21N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide [Supplementary Concept]1.393
22Fluoxetine1.102
23Amisulpride1.102
24Buspirone1.102
25Cabergoline1.102
26Dihydroergotamine1.102
27Guanfacine1.102
28Lisuride1.102
29Metoclopramide1.102
30Phenoxybenzamine1.102
31Piribedil1.102
32Tamsulosin1.102
33Amlodipine0.691
34cbd0.691
35Duloxetine Hydrochloride0.691
36Rutin0.691
37Sertraline0.691
38vinpocetine0.691
39Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent0.691
40Amoxapine0.691
41Aprindine0.691
42Astemizole Antihistamine drug now withdrawn from0.691
43Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
44cannabidiol0.691
45Chlorhexidine0.691
46cinacalcet0.691
47Crizotinib0.691
48Dihydroergocornine0.691
49Domperidone0.691
50Emetine0.691

Showing top 50 of 76 compounds. Use the BiohacksAI search to explore all ADRA2C modulators.

About ADRA2C as a Drug Target

ADRA2C (adrenoceptor alpha 2C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 76 compounds with documented ADRA2C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADRA2C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.